This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Growth Efforts to Aid Constellation Brands (STZ) Amid High Costs
by Zacks Equity Research
Constellation Brands (STZ) looks well-poised for growth on a solid beer unit, strong demand and its premiumization strategy. However, higher packaging and raw material costs are woes.
The J.M. Smucker's (SJM) Solid Pricing Aids Amid Cost Woes
by Zacks Equity Research
The J.M. Smucker (SJM) gains on efficient pricing amid cost inflation. A focus on core priorities and categories like coffee, snacking and pet are working well.
Keurig Dr Pepper (KDP) Cheers Investors With Dividend Hike
by Zacks Equity Research
Amid the rising cost concerns, Keurig Dr Pepper (KDP) rewards its shareholders with a dividend payment of 86 cents per share, payable on Oct 13, 2022.
AB InBev (BUD) on Track With Its Growth Efforts: Apt to Hold?
by Zacks Equity Research
Despite cost headwinds, AB InBev's (BUD) rapid expansion of its digital platform, solid demand and continued premiumization bode well.
Molson Coors (TAP) Extends ZOA Energy Deal to Expand Beyond Beer
by Zacks Equity Research
Molson Coors (TAP) increases its investment in ZOA Energy to strengthen its beyond beer portfolio.
Hostess Brands (TWNK) to be Acquired by The J.M. Smucker
by Zacks Equity Research
The acquisition of Hostess Brands (TWNK) by The J.M. Smucker aims to capitalize on the synergy between the two well-established consumer goods companies.
The J.M. Smucker (SJM) to Buy Hostess Brands: Things to Know
by Zacks Equity Research
The J.M. Smucker (SJM) to acquire Hostess Brands (TWNK) by third-quarter fiscal 2024. The deal is priced at $34.25 per share in a cash and stock transaction.
The J.M. Smucker (SJM) to Potentially Buy Hostess Brands
by Zacks Equity Research
Per reports, The J.M. Smucker Company (SJM) will likely acquire Hostess Brands (TWNK) for nearly $5 billion.
Can Strategic Growth Efforts Aid Clorox (CLX) Amid High Costs?
by Zacks Equity Research
Despite inflation concerns, Clorox (CLX) looks well-poised to drive growth on solid demand, pricing actions, cost-saving efforts and other growth strategies.
Can Strategic Growth Endeavors Aid Newell (NWL) Amid Inflation?
by Zacks Equity Research
Despite inflationary pressures, Newell (NWL) looks promising on the back of cost-cutting initiatives and a solid online show.
Hormel Foods (HRL) Stock Dips on Q3 Earnings & Sales Miss
by Zacks Equity Research
Hormel Foods' (HRL) third-quarter fiscal 2023 results reflect weakness in the Retail and International segments. Continued momentum in the Foodservice unit acts as an upside.
Church & Dwight (CHD) Up More Than 15% YTD: Will It Stay?
by Zacks Equity Research
Constant brand investments, product innovation, effective pricing actions and successful execution are contributing to Church & Dwight's (CHD) growth.
The Estee Lauder Companies (EL) Dips More Than 35%: Here's Why
by Zacks Equity Research
The Estee Lauder Companies (EL) is cautious about economic hurdles in China, volatile inflation levels, foreign currency fluctuations and concerns surrounding the recession.
Company News for Aug 30, 2023
by Zacks Equity Research
Companies in The News Are: BBY,SJM,GOGL,BNS
Strength in Brand Portfolio Aids Kellogg (K), Rising Costs Ail
by Zacks Equity Research
Kellogg (K) is focused on investing in brand-building efforts. However, adverse impacts of high input cost inflation and shortages are a concern.
Nu Skin (NUS) Down More Than 30% in 3 Months: Here's Why
by Zacks Equity Research
Nu Skin (NUS) is battling continued macroeconomic hurdles and related price increases, affecting specific key markets, leading to a slowdown in consumer spending and customer acquisition.
10 Drugs Selected for Medicare Price Reduction
by Zacks Equity Research
10 Drugs Selected for Medicare Price Reduction
Medicare Drugs Targeted Under Inflation Reduction Act
by Mark Vickery
Last year, these 10 drugs made up $50 billion, about 20%, of Medicare part D costs.
The J.M. Smucker (SJM) Raises EPS Guidance on Q1 Earnings Beat
by Zacks Equity Research
The J.M. Smucker's (SJM) first-quarter fiscal 2024 results reflect gains from favorable volumes and positive net price realization. Management raises the fiscal 2024 bottom-line guidance.
Smucker (SJM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Smucker (SJM) give a sense of how its business performed in the quarter ended July 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Smucker (SJM) Q1 Earnings Beat Estimates
by Zacks Equity Research
Smucker (SJM) delivered earnings and revenue surprises of 6.76% and 1.95%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?
Greif (GEF) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Greif's (GEF) third-quarter fiscal 2023 results are likely to reflect the impacts of lower volumes across its segments.
Titan Machinery (TITN) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Titan Machinery's (TITN) Q2 results are likely to reflect improved demand in the agriculture segment, higher parts revenues and revenues generated from rental and services.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Accelerate Strategy Aids General Mills (GIS), High Costs Hurt
by Zacks Equity Research
General Mills (GIS) is focused on its Accelerate strategy, which helps it make choices of how to win and where to play to boost profitability. However, cost inflation is a headwind.